Sponsored Ad | NIKKEI FORUM MELBOURNE 2025 - Leaderboard

Sinopharm-led group plans to take private HK-listed TCM in $3.3b deal

Sinopharm-led group plans to take private HK-listed TCM in $3.3b deal

Julia Zhou, Kane Wu

27 January, 2021

Printed by Unregistered user on Wed, 13 Aug 2025 11:49:51 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese healthcare group Sinopharm picks up stake in US firm AAT

China's AI-driven healthcare firm Synyi bags $36.3m led by Tencent, Sinopharm

Read more from Greater China

Earnings and Results

Tencent’s revenue grows 15% in Q2 as gaming, AI fuel growth

Climate Tech & ESG

Pricing reforms to slow China’s solar power capacity growth in H2